Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.34 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2139738 | 0.95 | FOLH1 (0.35) | FOLH1RNPEPSLC7A5MAPTALDH1A1 | |
| SCHEMBL2133523 | 0.93 | MAPT (0.36) | FOLH1RNPEPSLC7A5MAPT | |
| SCHEMBL2136393 | 0.85 | FOLH1 (0.36) | FOLH1RNPEPSLC7A5MAPT | |
| SCHEMBL2137667 | 0.85 | FOLH1 (0.35) | FOLH1RNPEPSLC7A5MAPTALDH1A1 | |
| SCHEMBL2132491 | 0.84 | MAPT (0.39) | FOLH1MAPTSLC1A3SLC1A2 | |
| SCHEMBL2139396 | 0.84 | MAPT (0.35) | FOLH1MAPT | |
| SCHEMBL2134437 | 0.84 | FOLH1 (0.35) | FOLH1RNPEPSLC7A5MAPTSLC1A3 | |
| SCHEMBL2135972 | 0.83 | MAPT (0.36) | FOLH1RNPEPSLC7A5MAPT | |
| SCHEMBL2134921 | 0.83 | MAPT (0.36) | FOLH1RNPEPSLC7A5MAPT | |
| SCHEMBL2137589 | 0.83 | FOLH1 (0.31) | FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120101294-A1 | PROCESS FOR PRODUCING (FLUOROALKYLTHIO) ACETIC ACID ESTER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101294-A1 | PROCESS FOR PRODUCING (FLUOROALKYLTHIO) ACETIC ACID ESTER | GRHPR, AKR7A2, FAR1 | FOLH1 1822/4885RNPEP 1177/4885SLC7A5 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.